← Back to patent-cliff list
盐酸伊伐布雷定/酒石酸美托洛尔
Tier C — Watch / tradeIvabradine Hydrochloride/Metoprolol Tartrate
Laboratoires Servier
Originator
2015
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：β-adrenoceptors、HCN channels
Brand：Implicor
Indications (approved)：心绞痛
Regional status
US
-
EU
批准上市
2015-01-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ivabradine Hydrochloride/Metoprolol Tartrate?
Approved indications include: 心绞痛.
When does the Ivabradine Hydrochloride/Metoprolol Tartrate patent expire?
No public expiry year is available for Ivabradine Hydrochloride/Metoprolol Tartrate yet; this page updates once verified.
How do I get a quote for Ivabradine Hydrochloride/Metoprolol Tartrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24